Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Amphastar Pharma (AMPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 939,016
  • Shares Outstanding, K 46,098
  • Annual Sales, $ 294,670 K
  • Annual Income, $ -5,740 K
  • 60-Month Beta 1.40
  • Price/Sales 3.16
  • Price/Cash Flow 27.66
  • Price/Book 2.56

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 0.03
  • Number of Estimates 3
  • High Estimate 0.07
  • Low Estimate -0.03
  • Prior Year -0.05
  • Growth Rate Est. (year over year) +160.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.70 +4.85%
on 03/14/19
25.43 -18.78%
on 03/04/19
-3.65 (-15.03%)
since 02/19/19
3-Month
18.89 +9.34%
on 12/26/18
25.43 -18.78%
on 03/04/19
-0.08 (-0.41%)
since 12/19/18
52-Week
14.40 +43.44%
on 05/10/18
25.43 -18.78%
on 03/04/19
+1.09 (+5.54%)
since 03/19/18

Most Recent Stories

More News
Amphastar Pharmaceuticals Receives FDA Approval for Enoxaparin Sodium Injection 300mg/3mL (100mg/mL) Multiple Dose Vial

Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) announced that the U.S. Food and Drug Administration (FDA) granted approval of its Abbreviated New Drug Application ("ANDA") for Enoxaparin Sodium Injection...

AMPH : 20.73 (+1.77%)
Amphastar Pharmaceuticals (AMPH) Beats Q4 Earnings and Revenue Estimates

Amphastar (AMPH) delivered earnings and revenue surprises of 30.00% and 18.85%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

AMPH : 20.73 (+1.77%)
Amphastar: 4Q Earnings Snapshot

RANCHO CUCAMONGA, Calif. (AP) _ Amphastar Pharmaceuticals Inc. (AMPH) on Tuesday reported fourth-quarter earnings of $1.9 million.

AMPH : 20.73 (+1.77%)
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2018

Reports Net Revenues of $89.7 Million for the Three Months Ended December 31, 2018

AMPH : 20.73 (+1.77%)
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 12, 2019

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its fourth quarter of 2018 ended December 31, 2018, after the market closes on Tuesday, March 12, 2019,...

AMPH : 20.73 (+1.77%)
35.7% Return Seen to Date on SmarTrend Amphastar Pharma Call (AMPH)

SmarTrend identified an Uptrend for Amphastar Pharma (NASDAQ:AMPH) on August 7th, 2018 at $17.83. In approximately 7 months, Amphastar Pharma has returned 35.65% as of today's recent price of $24.18.

AMPH : 20.73 (+1.77%)
Market Trends Toward New Normal in Micron Technology, Harris, Sientra, Noble, Amphastar Pharmaceuticals, and CECO Environmental -- Emerging Consolidated Expectations, Analyst Ratings

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Micron Technology, Inc....

NE : 3.06 (-1.61%)
MU : 40.61 (+2.52%)
HRS : 164.84 (+0.94%)
SIEN : 9.13 (-0.98%)
AMPH : 20.73 (+1.77%)
CECE : 7.63 (-1.29%)
36.7% Return Seen to Date on SmarTrend Amphastar Pharma Call (AMPH)

SmarTrend identified an Uptrend for Amphastar Pharma (NASDAQ:AMPH) on August 7th, 2018 at $17.83. In approximately 7 months, Amphastar Pharma has returned 36.72% as of today's recent price of $24.37.

AMPH : 20.73 (+1.77%)
MNK vs. AMPH: Which Stock Should Value Investors Buy Now?

MNK vs. AMPH: Which Stock Is the Better Value Option?

AMPH : 20.73 (+1.77%)
MNK : 23.22 (+2.25%)
Uptrend Call Working As Amphastar Pharma Stock Rises 30.0% (AMPH)

SmarTrend identified an Uptrend for Amphastar Pharma (NASDAQ:AMPH) on August 7th, 2018 at $17.83. In approximately 6 months, Amphastar Pharma has returned 29.99% as of today's recent price of $23.17.

AMPH : 20.73 (+1.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade AMPH with:

Business Summary

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and...

See More

Key Turning Points

2nd Resistance Point 20.73
1st Resistance Point 20.55
Last Price 20.73
1st Support Level 20.21
2nd Support Level 20.05

See More

52-Week High 25.43
Fibonacci 61.8% 21.22
Last Price 20.73
Fibonacci 50% 19.92
Fibonacci 38.2% 18.61
52-Week Low 14.40

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar